Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in TLX held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 565K | $5.4M | +357.0% | 0.169% | 0.00% |
| 2 | Portolan Capital Management, LLC | 541K | $5.2M | — | 0.162% | 0.28% |
| 3 | LAZARD ASSET MANAGEMENT LLC | 290K | $2.8M | +15.7% | 0.087% | 0.00% |
| 4 | PORTLAND INVESTMENT COUNSEL INC. | 266K | $2.5M | 0.0% | 0.080% | 0.82% |
| 5 | Private Advisor Group, LLC | 174K | $1.7M | +276.3% | 0.052% | 0.01% |
| 6 | Integrated Wealth Concepts LLC | 164K | $1.6M | — | 0.049% | 0.01% |
| 7 | Raiffeisen Bank International AG | 130K | $1.2M | — | 0.039% | 0.02% |
| 8 | MORGAN STANLEY | 116K | $1.1M | +559.6% | 0.035% | 0.00% |
| 9 | Mariner, LLC | 43K | $415K | +18.8% | 0.013% | 0.00% |
| 10 | Schonfeld Strategic Advisors LLC | 35K | $334K | — | 0.010% | 0.00% |
| 11 | JustInvest LLC | 33K | $318K | +83.3% | 0.010% | 0.00% |
| 12 | UBS Group AG | 32K | $309K | +1544.6% | 0.010% | 0.00% |
| 13 | XTX Topco Ltd | 26K | $249K | +120.0% | 0.008% | 0.00% |
| 14 | IHT Wealth Management, LLC | 25K | $240K | -1.0% | 0.007% | 0.01% |
| 15 | Vident Advisory, LLC | 17K | $159K | -38.9% | 0.005% | 0.00% |
| 16 | XY Capital Ltd | 13K | $120K | — | 0.004% | 0.13% |
| 17 | BNP PARIBAS ARBITRAGE, SA | 12K | $115K | +700.0% | 0.004% | 0.00% |
| 18 | BANK OF AMERICA CORP /DE/ | 10K | $96K | +523.8% | 0.003% | 0.00% |
| 19 | RHUMBLINE ADVISERS | 10K | $94K | -8.9% | 0.003% | 0.00% |
| 20 | EverSource Wealth Advisors, LLC | 169 | $16K | -81.2% | 0.000% | 0.00% |
| 21 | CWM, LLC | 1K | $14K | — | 0.000% | 0.00% |
| 22 | SRS Capital Advisors, Inc. | 125 | $10K | -88.5% | 0.000% | 0.00% |
| 23 | Larson Financial Group LLC | 899 | $9K | — | 0.000% | 0.00% |
| 24 | ADVISOR GROUP HOLDINGS, INC. | 756 | $7K | +140.8% | 0.000% | 0.00% |
| 25 | Blue Trust, Inc. | 742 | $7K | -76.0% | 0.000% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in TLX — a direct measure of their conviction.
Filings activity in TLX during Q1 2026, grouped by how each filer changed its position.
7 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 37 | 5.1% | 0.75% | +0.49 pp | $24M | +183% |
| Q4 2025 | 39 | +44% | 0.26% | +0.02 pp | $8M | +9.0% |
| Q3 2025 | 27 | +23% | 0.24% | +0.01 pp | $8M | +6.6% |
| Q2 2025 | 22 | +214% | 0.23% | +0.21 pp | $7M | +812% |
| Q1 2025 | 7 | +250% | 0.02% | +0.02 pp | $1M | +1290% |
| Q4 2024 | 2 | +100% | 0.00% | +0.00 pp | $0M | — |
| Q2 2024 | 1 | — | 0.00% | — | $0M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying TLX stock.
Based on Q1 2026 13F filings, institutional ownership of Telix Pharmaceuticals Limited stands at 0.8%, held across 37 reporting institutions.
FMR LLC is the largest reported institutional holder of TLX, with approximately 564,757 shares worth $0.01B as of Q1 2026.
No marquee "smart money" managers (Berkshire, Burry, ARK, Tiger Global, Pershing Square, Baupost, etc.) currently appear among the top 25 institutional holders of TLX.
Our composite Smart Money Score for TLX is 38 out of 100 (Bearish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
11 institutions opened new positions in TLX during Q1 2026, while 13 fully exited. 22 added to existing positions and 4 trimmed.
TLX institutional ownership rose by 0.49 percentage points quarter-over-quarter, with a net change of -2 holders.
The top 10 institutions account for 92.6% of all reported 13F value in TLX, and the top 25 account for 99.9%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Telix Pharmaceuticals Limited (TLX) Institutional Ownership